Document Detail


Case report: Death associated with stroke following intracarotid amobarbital testing.
MedLine Citation:
PMID:  20075010     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: One previous accidental death during intracarotid amobarbital testing (IAT) associated with cerebral angiography (CA) has been reported in the literature. The objectives of this article are to briefly review morbidity and mortality risks for patients undergoing diagnostic CA and to describe a case with a fatal outcome. METHOD: The case of a 38-year-old man who had a right middle cerebral artery stroke while undergoing IAT is described. The patient was not high risk by Centers for Medicare and Medicaid Services criteria or invasive procedures; neither did he have risk factors for embolic stroke. CONCLUSIONS: A problem noted is that IAT procedures vary from center to center and that IAT may increase the risk for individual patients because of differences between IAT and other CA interventions.
Authors:
James English; Brad Davis
Publication Detail:
Type:  Case Reports; Journal Article     Date:  2010-01-13
Journal Detail:
Title:  Epilepsy & behavior : E&B     Volume:  17     ISSN:  1525-5069     ISO Abbreviation:  Epilepsy Behav     Publication Date:  2010 Feb 
Date Detail:
Created Date:  2010-02-15     Completed Date:  2010-05-21     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100892858     Medline TA:  Epilepsy Behav     Country:  United States    
Other Details:
Languages:  eng     Pagination:  283-4     Citation Subset:  IM    
Copyright Information:
(c) 2009 Elsevier Inc. All rights reserved.
Affiliation:
University of Nebraska Medical Center, Omaha, NE 68198-4185, USA. painsanatomy@msn.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Amobarbital / adverse effects*,  diagnostic use*
Cerebral Angiography
Epilepsies, Partial / physiopathology
Fatal Outcome
Humans
Infarction, Middle Cerebral Artery / etiology*
Male
Chemical
Reg. No./Substance:
57-43-2/Amobarbital

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Prevalence of anxiety disorders in patients with refractory focal epilepsy-a prospective clinic base...
Next Document:  A review of Savant Syndrome and its possible relationship to epilepsy.